Students can prepare for the ICSE Class 10 History & Civics exam on March 16, 2026, with expert-curated sample questions.

The Tennessee Vols could be on the verge of receiving some very good recruiting news. 2027 four-star wide receiver Kesean Bowman is one of the Vols' top recruiting targets. Bowman, 6-foot-1/174 pounds ...

That shared DNA makes the first collaboration between Timberland PRO and Ford feel natural, bringing together two American names long associated with durability, grit and getting the job done. Few ...

Advancing AX-0810 through ongoing Phase 1 dosing, with target engagement data expected 1H 2026Selected Development Candidates AX-2402 for Rett ...

Enrollment has been completed for a phase 2a randomized clinical trial evaluating the investigational microbiome therapeutic EBX-102-02 in patients undergoing allogeneic hematopoietic stem cell ...

The Tennessee Vols are reportedly a threat to swipe a 2027 football commit from the Alabama Crimson Tide. According to On3's Chad Simmons, the Volunteers are one of the programs in the mix for 2027 ...

Don’t get old before your time. A number of very common everyday habits can accelerate biological aging, putting extra stress on your cells and organs and making yourself more susceptible to certain ...

Discover the best home-improvement products—lab-tested, expert-approved upgrades for kitchens, baths, and beyond from Good ...

Allentown sixth-graders are experimenting with an artificial-intelligence-powered program that one student called “basically a teacher online,” and educators themselves say helps them provide timely ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Trexler Middle School teacher Richard Ares works Thursday, Feb. 12, 2026, with sixth graders Arron Souffront, Zoey Rodriguez and Alaisha Reyes on Allentown School District’s pilot program of ...

Advancing AX-0810 through ongoing Phase 1 dosing, with target engagement data expected 1H 2026Selected Development Candidates AX-2402 for Rett syndrome (MECP2, R270X) and AX-2911 for MASH (PNPLA3)Ende ...